Xcout Intel
Pharmacelera
Pharmacelera is a computational chemistry company based in Barcelona, Spain, that provides drug discovery services and solutions for biotech and pharmaceutical clients.
Subscribe to see Pharmacelera’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Pharmacelera at a glance
Pharmacelera is a drug discovery company headquartered in Spain. Its most recent funding round, Series A, raised $6M in February 2026. Xcout tracks 17 named people at Pharmacelera, including Enric Gibert (Chief Executive Officer).
Pharmacelera leadership
- Enric GibertChief Executive Officer
- Greta CánovasCFO
- Remy HoffmannCDBO
- Enric GibertCEO & Co-founder
- Enric HerreroCTO & Co-founder
- Javier LuqueCSO & Co-founder
11 more named people on record for Pharmacelera, with roles, board committees and tenure — see the full roster →
Pharmacelera funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $6M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Pharmacelera competitors
A few of Pharmacelera's closest competitors — see the full list of competitors and alternatives →
Prescience Insilico provides AI-driven software platforms and R&D services for drug discovery and materials science innovation.
Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating small molecule therapeutics utilizing targeted protein degradation technology for novel drug discovery.
Variational AI is a privately held biotechnology startup headquartered in Vancouver, British Columbia. Founded in 2019, the company focuses on drug discovery, utilizing artificial intelligence to identify novel drug-like small molecules. Recognized as an innovative AI enterprise in Canada, it develops advanced computational methods for pharmaceutical research.
Generare is a biotechnology and artificial intelligence company headquartered in Paris, France, focused on commercial bioprospecting and decoding natural products.
Iktos is a privately held biotechnology company headquartered in Paris, France, specializing in generative AI and robotics for drug discovery. Its generative AI platform, Makya, designs molecules optimized for robotic synthesis.
Qubit Pharmaceuticals is a privately held company headquartered in Paris, France, that brings precision to drug discovery and design by utilizing cutting-edge quantum physics-based science to develop life-changing treatments.
Get Pharmacelera's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Pharmacelera in Xcout Intel
- 17 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access